Free for academic non-profit institutions. Other users need a Commercial license

Aliases for FLT4 Gene

Aliases for FLT4 Gene

  • Fms Related Tyrosine Kinase 4 2 3
  • Fms-Related Tyrosine Kinase 4 2 3 5
  • Tyrosine-Protein Kinase Receptor FLT4 3 4
  • Fms-Like Tyrosine Kinase 4 3 4
  • EC 2.7.10.1 4 63
  • VEGFR-3 3 4
  • VEGFR3 3 4
  • FLT-4 3 4
  • EC 2.7.10 63
  • LMPH1A 3
  • FLT41 3
  • PCL 3

External Ids for FLT4 Gene

Previous GeneCards Identifiers for FLT4 Gene

  • GC05M180162
  • GC05M181012
  • GC05M180139
  • GC05M180132
  • GC05M179962
  • GC05M180028
  • GC05M174752

Summaries for FLT4 Gene

Entrez Gene Summary for FLT4 Gene

  • This gene encodes a tyrosine kinase receptor for vascular endothelial growth factors C and D. The protein is thought to be involved in lymphangiogenesis and maintenance of the lymphatic endothelium. Mutations in this gene cause hereditary lymphedema type IA. [provided by RefSeq, Jul 2008]

GeneCards Summary for FLT4 Gene

FLT4 (Fms Related Tyrosine Kinase 4) is a Protein Coding gene. Diseases associated with FLT4 include lymphedema, hereditary, ia and hemangioma, capillary infantile. Among its related pathways are PEDF Induced Signaling and Focal Adhesion. GO annotations related to this gene include transferase activity, transferring phosphorus-containing groups and protein tyrosine kinase activity. An important paralog of this gene is FGFR1.

UniProtKB/Swiss-Prot for FLT4 Gene

  • Tyrosine-protein kinase that acts as a cell-surface receptor for VEGFC and VEGFD, and plays an essential role in adult lymphangiogenesis and in the development of the vascular network and the cardiovascular system during embryonic development. Promotes proliferation, survival and migration of endothelial cells, and regulates angiogenic sprouting. Signaling by activated FLT4 leads to enhanced production of VEGFC, and to a lesser degree VEGFA, thereby creating a positive feedback loop that enhances FLT4 signaling. Modulates KDR signaling by forming heterodimers. The secreted isoform 3 may function as a decoy receptor for VEGFC and/or VEGFD and play an important role as a negative regulator of VEGFC-mediated lymphangiogenesis and angiogenesis. Binding of vascular growth factors to isoform 1 or isoform 2 leads to the activation of several signaling cascades; isoform 2 seems to be less efficient in signal transduction, because it has a truncated C-terminus and therefore lacks several phosphorylation sites. Mediates activation of the MAPK1/ERK2, MAPK3/ERK1 signaling pathway, of MAPK8 and the JUN signaling pathway, and of the AKT1 signaling pathway. Phosphorylates SHC1. Mediates phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase. Promotes phosphorylation of MAPK8 at Thr-183 and Tyr-185, and of AKT1 at Ser-473.

Tocris Summary for FLT4 Gene

  • Vascular endothelial growth factor is a signaling protein involved in the regulation of angiogenesis and vasculogenesis. VEGF binds to and activates a receptor tyrosine kinase, VEGFR, through transphosphorylation. Three VEGFR isoforms have been identified in humans.

Gene Wiki entry for FLT4 Gene

No data available for PharmGKB "VIP" Summary , fRNAdb sequence ontologies and piRNA Summary for FLT4 Gene

Genomics for FLT4 Gene

Regulatory Elements for FLT4 Gene

Enhancers for FLT4 Gene
GeneHancer Identifier Score Enhancer Sources TSS distance (kb) Number of Genes Away Size (kb) Transcription Factor Binding Sites within enhancer Other Gene Targets for Enhancer

Enhancers around FLT4 on UCSC Golden Path with GeneCards custom track

Promoters for FLT4 Gene
Ensembl Regulatory Elements (ENSRs) TSS Distance (bp) Size (bp) Binding Sites for Transcription Factors within promoters

ENSRs around FLT4 on UCSC Golden Path with GeneCards custom track

Genomic Location for FLT4 Gene

Chromosome:
5
Start:
180,601,506 bp from pter
End:
180,650,271 bp from pter
Size:
48,766 bases
Orientation:
Minus strand

Genomic View for FLT4 Gene

Genes around FLT4 on UCSC Golden Path with GeneCards custom track

Cytogenetic band:
FLT4 Gene in genomic location: bands according to Ensembl, locations according to GeneLoc (and/or Entrez Gene and/or Ensembl if different)
Genomic Location for FLT4 Gene
GeneLoc Logo Genomic Neighborhood Exon StructureGene Density

RefSeq DNA sequence for FLT4 Gene

Proteins for FLT4 Gene

  • Protein details for FLT4 Gene (UniProtKB/Swiss-Prot)

    Protein Symbol:
    P35916-VGFR3_HUMAN
    Recommended name:
    Vascular endothelial growth factor receptor 3
    Protein Accession:
    P35916
    Secondary Accessions:
    • A8K6L4
    • B5A926
    • Q16067
    • Q86W07
    • Q86W08

    Protein attributes for FLT4 Gene

    Size:
    1363 amino acids
    Molecular mass:
    152757 Da
    Quaternary structure:
    • Interacts with VEGFC and VEGFD. Monomer in the absence of bound VEGFC or VEGFD. Homodimer in the presence of bound VEGFC or VEGFD. Can also form a heterodimer with KDR. Interacts with PTPN14; the interaction is enhanced by stimulation with VEGFC. Interacts with CRK, GRB2, PTK2/FAK1, SHC1, PIK3R1 and PTPN11/SHP-2. Identified in a complex with SRC and ITGB1.
    SequenceCaution:
    • Sequence=CAA48290.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};

    Three dimensional structures from OCA and Proteopedia for FLT4 Gene

    Alternative splice isoforms for FLT4 Gene

    UniProtKB/Swiss-Prot:

neXtProt entry for FLT4 Gene

Proteomics data for FLT4 Gene at MOPED

Post-translational modifications for FLT4 Gene

  • Autophosphorylated on tyrosine residues upon ligand binding. Autophosphorylation occurs in trans, i.e. one subunit of the dimeric receptor phosphorylates tyrosine residues on the other subunit. Phosphorylation in response to H(2)O(2) is mediated by a process that requires SRC and PRKCD activity. Phosphorylation at Tyr-1068 is required for autophosphorylation at additional tyrosine residues. Phosphorylation at Tyr-1063 and Tyr-1337 is important for interaction with CRK and subsequent activation of MAPK8. Phosphorylation at Tyr-1230, Tyr-1231 and Tyr-1337 is important for interaction with GRB2 and subsequent activation of the AKT1 and MAPK1/ERK2 and/or MAPK3/ERK1 signaling pathways. In response to endothelial cell adhesion onto collagen, can also be phosphorylated in the absence of FLT4 kinase activity by SRC at Tyr-830, Tyr-833, Tyr-853, Tyr-1063, Tyr-1333, and Tyr-1337.
  • Ubiquitination at Lys 1253
  • Glycosylation at Asn 33, Asn 104, Asn 166, Asn 251, Asn 299, Asn 411, Asn 515, Asn 527, Asn 594, Asn 683, Asn 690, and Asn 758
  • Modification sites at PhosphoSitePlus

Other Protein References for FLT4 Gene

Antibody Products

  • Cell Signaling Technology (CST) Antibodies for FLT4 (VEGFR3)

Protein Products

Domains & Families for FLT4 Gene

Graphical View of Domain Structure for InterPro Entry

P35916

UniProtKB/Swiss-Prot:

VGFR3_HUMAN :
  • The first and second Ig-like C2-type (immunoglobulin-like) domains are sufficient for VEGFC binding.
  • Belongs to the protein kinase superfamily. Tyr protein kinase family. CSF-1/PDGF receptor subfamily.
Domain:
  • The first and second Ig-like C2-type (immunoglobulin-like) domains are sufficient for VEGFC binding.
  • Contains 7 Ig-like C2-type (immunoglobulin-like) domains.
  • Contains 1 protein kinase domain.
Family:
  • Belongs to the protein kinase superfamily. Tyr protein kinase family. CSF-1/PDGF receptor subfamily.
genes like me logo Genes that share domains with FLT4: view

Function for FLT4 Gene

Molecular function for FLT4 Gene

GENATLAS Biochemistry:
fms-related receptor t tyrosine kinase 4,expressed on the surface on endothelial cells
UniProtKB/Swiss-Prot CatalyticActivity:
ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.
UniProtKB/Swiss-Prot EnzymeRegulation:
Present in an inactive conformation in the absence of bound ligand. Binding of VEGFC or VEGFD leads to dimerization and activation by autophosphorylation on tyrosine residues. Inhibited by MAZ51.
UniProtKB/Swiss-Prot Function:
Tyrosine-protein kinase that acts as a cell-surface receptor for VEGFC and VEGFD, and plays an essential role in adult lymphangiogenesis and in the development of the vascular network and the cardiovascular system during embryonic development. Promotes proliferation, survival and migration of endothelial cells, and regulates angiogenic sprouting. Signaling by activated FLT4 leads to enhanced production of VEGFC, and to a lesser degree VEGFA, thereby creating a positive feedback loop that enhances FLT4 signaling. Modulates KDR signaling by forming heterodimers. The secreted isoform 3 may function as a decoy receptor for VEGFC and/or VEGFD and play an important role as a negative regulator of VEGFC-mediated lymphangiogenesis and angiogenesis. Binding of vascular growth factors to isoform 1 or isoform 2 leads to the activation of several signaling cascades; isoform 2 seems to be less efficient in signal transduction, because it has a truncated C-terminus and therefore lacks several phosphorylation sites. Mediates activation of the MAPK1/ERK2, MAPK3/ERK1 signaling pathway, of MAPK8 and the JUN signaling pathway, and of the AKT1 signaling pathway. Phosphorylates SHC1. Mediates phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase. Promotes phosphorylation of MAPK8 at Thr-183 and Tyr-185, and of AKT1 at Ser-473.

Enzyme Numbers (IUBMB) for FLT4 Gene

Gene Ontology (GO) - Molecular Function for FLT4 Gene

GO ID Qualified GO term Evidence PubMed IDs
GO:0004672 protein kinase activity IEA --
GO:0004713 protein tyrosine kinase activity IEA --
genes like me logo Genes that share ontologies with FLT4: view
genes like me logo Genes that share phenotypes with FLT4: view

Human Phenotype Ontology for FLT4 Gene

HPO Id HPO Name Alternative Ids Definition Synonyms

Animal Models for FLT4 Gene

MGI Knock Outs for FLT4:

Animal Model Products

miRNA for FLT4 Gene

miRTarBase miRNAs that target FLT4

Inhibitory RNA Products

In Situ Assay Products

Flow Cytometry Products

No data available for Transcription Factor Targets and HOMER Transcription for FLT4 Gene

Localization for FLT4 Gene

Subcellular locations from UniProtKB/Swiss-Prot for FLT4 Gene

Cell membrane; Single-pass type I membrane protein. Cytoplasm. Nucleus. Note=Ligand-mediated autophosphorylation leads to rapid internalization.
Isoform 1: Cell membrane; Single-pass type I membrane protein. Note=Ligand-mediated autophosphorylation leads to rapid internalization.
Isoform 2: Cell membrane; Single-pass type I membrane protein.
Isoform 3: Secreted. Cytoplasm.

Subcellular locations from

COMPARTMENTS
Jensen Localization Image for FLT4 Gene COMPARTMENTS Subcellular localization image for FLT4 gene
Compartment Confidence
extracellular 5
nucleus 5
plasma membrane 5
cytoskeleton 1
endoplasmic reticulum 1

No data available for Gene Ontology (GO) - Cellular Components for FLT4 Gene

Pathways & Interactions for FLT4 Gene

genes like me logo Genes that share pathways with FLT4: view

SIGNOR curated interactions for FLT4 Gene

Activates:
Is activated by:
Other effect:

Gene Ontology (GO) - Biological Process for FLT4 Gene

GO ID Qualified GO term Evidence PubMed IDs
GO:0001945 lymph vessel development ISS --
GO:0006468 protein phosphorylation IEA --
GO:0007169 transmembrane receptor protein tyrosine kinase signaling pathway IEA,TAS 10835628
GO:0008284 positive regulation of cell proliferation IMP 7675451
GO:0010575 positive regulation of vascular endothelial growth factor production IMP 19779139
genes like me logo Genes that share ontologies with FLT4: view

Drugs & Compounds for FLT4 Gene

(73) Drugs for FLT4 Gene - From: DrugBank, PharmGKB, ApexBio, DGIdb, FDA Approved Drugs, IUPHAR, HMDB, Tocris, and Novoseek

Name Status Disease Links Group Role Mechanism of Action Clinical Trials
Sunitinib Approved, Investigational Pharma inhibitor, Target, antagonist VEGFR/PDGFRβ/ KIT/ FLT3/RET/CSF-1R inhibitor, RTK inhibitor, Kinase Inhibitors, Vascular endothelial growth factor (VEGF) and VEGF receptor (VEGFR) inhibitors, Potent VEGFR, PDGFRbeta and KIT inhibitor 490
Sorafenib Approved, Investigational Pharma inhibitors, inhibitor, Target, antagonist Raf kinases and tyrosine kinases inhibitor, RAF, VEGFR2, and PDGFR-beta inhibitors, Kinase Inhibitors, Vascular endothelial growth factor (VEGF) and VEGF receptor (VEGFR) inhibitors 677
Pazopanib Approved Pharma inhibitor, Target VEFGR, c-Kit, and PDGFR inhibitor, Kinase Inhibitors, Vascular endothelial growth factor (VEGF) and VEGF receptor (VEGFR) inhibitors 0
regorafenib Approved Pharma inhibitor, Target Inhibitor of VEGFR/PDGFR/FGFR/mutant kit/RET/Raf-1, Kinase Inhibitors, Vascular endothelial growth factor (VEGF) and VEGF receptor (VEGFR) inhibitors 0
Axitinib Approved, Investigational Pharma Inhibition, inhibitor, Target Kinase Inhibitors, Vascular endothelial growth factor (VEGF) and VEGF receptor (VEGFR) inhibitors 103

(11) Additional Compounds for FLT4 Gene - From: HMDB, Novoseek, and Tocris

Name Synonyms Role CAS Number PubChem IDs PubMed IDs
ADP
  • Adenosindiphosphorsaeure
  • Adenosine 5'-pyrophosphate
  • Adenosine diphosphate
  • Adenosine pyrophosphate
  • Adenosine-5'-diphosphate
Full agonist, Agonist 58-64-0
AG 879
148741-30-4
ZM 306416 hydrochloride
196603-47-1
ZM 323881 hydrochloride
193000-39-4

(5) Tocris Compounds for FLT4 Gene

Compound Action Cas Number
AG 879 TrkA inhibitor 148741-30-4
Ki 8751 Potent, selective VEGFR-2 inhibitor 228559-41-9
SU 4312 Potent inhibitor of VEGFR tyrosine kinase 5812-07-7
ZM 306416 hydrochloride Inhibitor of VEGF receptor tyrosine kinase 196603-47-1
ZM 323881 hydrochloride Potent, selective inhibitor of VEGFR-2 193000-39-4

(19) ApexBio Compounds for FLT4 Gene

Compound Action Cas Number
BIBF 1120 VEGFR/PDGF/FGFR inhibitor 656247-17-5
Cabozantinib (XL184, BMS-907351) VEGFR2/Met/Ret/Kit/FLT//AXL inhibitor 849217-68-1
Cediranib (AZD217) VEGFR inhibitor receptor,highly potent 288383-20-0
Dovitinib Dilactic acid 852433-84-2
Foretinib (GSK1363089) VEGF and HGF receptor inhibitor 849217-64-7
Ki8751 VEGFR-2 inhibitor,potent and selective 228559-41-9
KRN 633 VEGFR inhibitor,ATP-competitive 286370-15-8
Lenvatinib (E7080) VEGFR inhibitor 417716-92-8
Motesanib Diphosphate (AMG-706) VEGFR/ PDGFR/c-Kit/Ret inhibitor 857876-30-3
Pazopanib (GW-786034) VEGFR/PDGFR/FGFR inhibitor 635702-64-6
Pazopanib Hydrochloride VEGFR/PDGFR/FGFR/c-Kit/ c-Fms inhibitor 635702-64-6
PD 173074 FGFR inhibitor 219580-11-7
SAR131675 VEGFR3 inhibitor,selective and ATP-competitve 1433953-83-3
SKLB610 Potent VEGFR inhibitor 1125780-41-7
SU 4312 5812-07-7
Sunitinib RTK inhibitor 557795-19-4
Telatinib (BAY 57-9352) VEGFR-2/-3,PDGFR-β and c-Kit inhibitor 332012-40-5
Tivozanib (AV-951) VEGFR inhibitor,potent and selective 475108-18-0
Vatalanib (PTK787) 2HCl Tyrosine kinase receptor inhibitor 212141-51-0
genes like me logo Genes that share compounds with FLT4: view

Drug Products

Transcripts for FLT4 Gene

Unigene Clusters for FLT4 Gene

Fms-related tyrosine kinase 4:
Representative Sequences:

Alternative Splicing Database (ASD) splice patterns (SP) for FLT4 Gene

No ASD Table

Relevant External Links for FLT4 Gene

GeneLoc Exon Structure for
FLT4
ECgene alternative splicing isoforms for
FLT4

Expression for FLT4 Gene

mRNA expression in normal human tissues for FLT4 Gene

mRNA expression in embryonic tissues and stem cells from LifeMap Discovery

mRNA differential expression in normal tissues according to GTEx for FLT4 Gene

This gene is overexpressed in Thyroid (x4.3).

Protein differential expression in normal tissues from HIPED for FLT4 Gene

This gene is overexpressed in Serum (56.2).

Integrated Proteomics: protein expression in normal tissues and cell lines from ProteomicsDB, PaxDb, and MOPED for FLT4 Gene



SOURCE GeneReport for Unigene cluster for FLT4 Gene Hs.646917

mRNA Expression by UniProt/SwissProt for FLT4 Gene

P35916-VGFR3_HUMAN
Tissue specificity: Detected in endothelial cells (at protein level). Widely expressed. Detected in fetal spleen, lung and brain. Detected in adult liver, muscle, thymus, placenta, lung, testis, ovary, prostate, heart, and kidney.
genes like me logo Genes that share expression patterns with FLT4: view

Protein tissue co-expression partners for FLT4 Gene

Primer Products

In Situ Assay Products

Orthologs for FLT4 Gene

This gene was present in the common ancestor of animals.

Orthologs for FLT4 Gene

Organism Taxonomy Gene Similarity Type Details
cow
(Bos Taurus)
Mammalia FLT4 35
  • 86.47 (n)
  • 86.47 (a)
FLT4 36
  • 84 (a)
OneToOne
dog
(Canis familiaris)
Mammalia FLT4 35
  • 88.15 (n)
  • 88.55 (a)
FLT4 36
  • 87 (a)
OneToOne
mouse
(Mus musculus)
Mammalia Flt4 35
  • 85.3 (n)
  • 87.45 (a)
Flt4 16
Flt4 36
  • 87 (a)
OneToOne
chimpanzee
(Pan troglodytes)
Mammalia FLT4 35
  • 98.56 (n)
  • 98.75 (a)
FLT4 36
  • 99 (a)
OneToOne
rat
(Rattus norvegicus)
Mammalia Flt4 35
  • 84.98 (n)
  • 87.09 (a)
oppossum
(Monodelphis domestica)
Mammalia FLT4 36
  • 76 (a)
OneToOne
platypus
(Ornithorhynchus anatinus)
Mammalia -- 36
  • 71 (a)
OneToMany
-- 36
  • 69 (a)
OneToMany
chicken
(Gallus gallus)
Aves FLT4 35
  • 72.13 (n)
  • 70.92 (a)
FLT4 36
  • 68 (a)
OneToOne
lizard
(Anolis carolinensis)
Reptilia FLT4 36
  • 67 (a)
OneToOne
tropical clawed frog
(Silurana tropicalis)
Amphibia LOC100493801 35
  • 63.74 (n)
  • 64.64 (a)
zebrafish
(Danio rerio)
Actinopterygii flt4 35
  • 60.63 (n)
  • 56.82 (a)
flt4 36
  • 53 (a)
OneToOne
fruit fly
(Drosophila melanogaster)
Insecta tor 37
  • 50 (a)
Cad96Ca 36
  • 28 (a)
ManyToMany
Pvr 36
  • 21 (a)
ManyToMany
sea squirt
(Ciona savignyi)
Ascidiacea -- 36
  • 35 (a)
OneToMany
Species with no ortholog for FLT4:
  • A. gosspyii yeast (Ashbya gossypii)
  • Actinobacteria (Mycobacterium tuberculosis)
  • African clawed frog (Xenopus laevis)
  • African malaria mosquito (Anopheles gambiae)
  • Alicante grape (Vitis vinifera)
  • alpha proteobacteria (Wolbachia pipientis)
  • amoeba (Dictyostelium discoideum)
  • Archea (Pyrococcus horikoshii)
  • baker's yeast (Saccharomyces cerevisiae)
  • barley (Hordeum vulgare)
  • beta proteobacteria (Neisseria meningitidis)
  • bread mold (Neurospora crassa)
  • Chromalveolata (Phytophthora infestans)
  • common water flea (Daphnia pulex)
  • corn (Zea mays)
  • E. coli (Escherichia coli)
  • filamentous fungi (Aspergillus nidulans)
  • Firmicute bacteria (Streptococcus pneumoniae)
  • fission yeast (Schizosaccharomyces pombe)
  • green algae (Chlamydomonas reinhardtii)
  • honey bee (Apis mellifera)
  • K. lactis yeast (Kluyveromyces lactis)
  • loblloly pine (Pinus taeda)
  • malaria parasite (Plasmodium falciparum)
  • medicago trunc (Medicago Truncatula)
  • moss (Physcomitrella patens)
  • orangutan (Pongo pygmaeus)
  • pig (Sus scrofa)
  • rainbow trout (Oncorhynchus mykiss)
  • rice (Oryza sativa)
  • rice blast fungus (Magnaporthe grisea)
  • schistosome parasite (Schistosoma mansoni)
  • sea anemone (Nematostella vectensis)
  • sea urchin (Strongylocentrotus purpuratus)
  • sorghum (Sorghum bicolor)
  • soybean (Glycine max)
  • stem rust fungus (Puccinia graminis)
  • sugarcane (Saccharum officinarum)
  • thale cress (Arabidopsis thaliana)
  • tomato (Lycopersicon esculentum)
  • toxoplasmosis (Toxoplasma gondii)
  • Trichoplax (Trichoplax adhaerens)
  • wheat (Triticum aestivum)
  • worm (Caenorhabditis elegans)

Evolution for FLT4 Gene

ENSEMBL:
Gene Tree for FLT4 (if available)
TreeFam:
Gene Tree for FLT4 (if available)

Paralogs for FLT4 Gene

genes like me logo Genes that share paralogs with FLT4: view

Variants for FLT4 Gene

Sequence variations from dbSNP and Humsavar for FLT4 Gene

SNP ID Clin Chr 05 pos Sequence Context AA Info Type
rs307826 - 180,624,003(-) TGACC(A/G/T)CGCAG nc-transcript-variant, reference, missense
rs55667289 - 180,621,641(+) GCGGG(A/G)GATAC nc-transcript-variant, reference, missense
VAR_018409 Lymphedema, hereditary, 1A (LMPH1A)
rs448012 - 180,619,344(+) GCGCG(C/G)TGCTC nc-transcript-variant, reference, missense
rs34255532 Hemangioma, capillary infantile (HCI) 180,618,911(-) AGTCT(C/T)CCGAG nc-transcript-variant, reference, missense

Structural Variations from Database of Genomic Variants (DGV) for FLT4 Gene

Variant ID Type Subtype PubMed ID
nsv509111 CNV Insertion 20534489
dgv6404n71 CNV Loss 21882294
dgv6405n71 CNV Loss 21882294
nsv462585 CNV Loss 19166990
nsv883296 CNV Gain 21882294
nsv528843 CNV Loss 19592680
nsv883297 CNV Loss 21882294
esv1734970 CNV Insertion 17803354
nsv528522 CNV Loss 19592680
esv27625 CNV Gain+Loss 19812545
esv2731345 CNV Deletion 23290073
nsv328308 CNV Loss 16902084
esv1125232 CNV Insertion 17803354
esv2731346 CNV Deletion 23290073
esv1677986 CNV Insertion 17803354
esv2731347 CNV Deletion 23290073
esv1000883 CNV Loss 20482838
nsv820663 CNV Deletion 20802225
nsv883298 CNV Loss 21882294
nsv522563 CNV Loss 19592680
esv1049221 CNV Deletion 17803354
esv2387627 CNV Deletion 18987734
esv4093 CNV Deletion 18987735
esv2731348 CNV Deletion 23290073
esv2665740 CNV Deletion 23128226
nsv830565 CNV Loss 17160897

Variation tolerance for FLT4 Gene

Residual Variation Intolerance Score: 17.7% of all genes are more intolerant (likely to be disease-causing)
Gene Damage Index Score: 5.66; 72.83% of all genes are more intolerant (likely to be disease-causing)

Relevant External Links for FLT4 Gene

HapMap Linkage Disequilibrium report
FLT4
Human Gene Mutation Database (HGMD)
FLT4

No data available for Polymorphic Variants from UniProtKB/Swiss-Prot for FLT4 Gene

Disorders for FLT4 Gene

MalaCards: The human disease database

(33) MalaCards diseases for FLT4 Gene - From: OMIM, ClinVar, GeneTests, Swiss-Prot, DISEASES, Novoseek, and GeneCards

Disorder Aliases PubMed IDs
lymphedema, hereditary, ia
  • nonne-milroy lymphedema
hemangioma, capillary infantile
  • hemangioma, capillary infantile, somatic
lymphedema
  • lymphatic edema
hereditary lymphedema
  • milroy's disease
hemangioma
- elite association - COSMIC cancer census association via MalaCards
Search FLT4 in MalaCards View complete list of genes associated with diseases

UniProtKB/Swiss-Prot

VGFR3_HUMAN
  • Hemangioma, capillary infantile (HCI) [MIM:602089]: A condition characterized by dull red, firm, dome-shaped hemangiomas, sharply demarcated from surrounding skin, usually presenting at birth or occurring within the first two or three months of life. They result from highly proliferative, localized growth of capillary endothelium and generally undergo regression and involution without scarring. {ECO:0000269 PubMed:11807987}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.
  • Lymphedema, hereditary, 1A (LMPH1A) [MIM:153100]: A chronic disabling condition which results in swelling of the extremities due to altered lymphatic flow. Patients with lymphedema suffer from recurrent local infections and physical impairment. {ECO:0000269 PubMed:10835628, ECO:0000269 PubMed:10856194, ECO:0000269 PubMed:16924388, ECO:0000269 PubMed:16965327, ECO:0000269 PubMed:17458866, ECO:0000269 PubMed:19289394, ECO:0000269 PubMed:26091405, ECO:0000269 PubMed:9817924}. Note=The disease is caused by mutations affecting the gene represented in this entry.
  • Note=Plays an important role in tumor lymphangiogenesis, in cancer cell survival, migration, and formation of metastases.

Relevant External Links for FLT4

Genetic Association Database (GAD)
FLT4
Human Genome Epidemiology (HuGE) Navigator
FLT4
Atlas of Genetics and Cytogenetics in Oncology and Haematology:
FLT4
genes like me logo Genes that share disorders with FLT4: view

No data available for Genatlas for FLT4 Gene

Publications for FLT4 Gene

  1. Chromosomal localization of FLT4, a novel receptor-type tyrosine kinase gene. (PMID: 1319394) Galland F. … Birnbaum D. (Genomics 1992) 2 3 4 23 67
  2. Sorafenib and sunitinib in the treatment of advanced non-small cell lung cancer. (PMID: 17296815) Gridelli C. … Rossi A. (Oncologist 2007) 23 25 26
  3. Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteins. (PMID: 17605814) Deprimo S.E. … Motzer R.J. (J Transl Med 2007) 23 25 26
  4. Lack of effect of ketoconazole-mediated CYP3A inhibition on sorafenib clinical pharmacokinetics. (PMID: 16133532) Lathia C. … Sundaresan P. (Cancer Chemother. Pharmacol. 2006) 23 25 26
  5. Comparative integromics on VEGF family members. (PMID: 16685460) Katoh Y. … Katoh M. (Int. J. Oncol. 2006) 23 25 26

Products for FLT4 Gene

  • Addgene plasmids for FLT4

Sources for FLT4 Gene

Content